Pfizer Warns Physicians about Possible Carcinogen
Pfizer, Incorporated (NYSE: PFE), is contacting healthcare professionals to warn them about a potential carcinogen in Viracept (nelfinavir), a medication used to help control human immunodeficiency virus infections.
The possible carcinogen is known as ethyl methanesulfonate, or EMS. According to the U.S. Food and Drug Administration, EMS has been shown to be teratogenic, mutagenic, and carcinogenic in animal studies.
Both the FDA and Pfizer agree the benefits of using Viracept outweigh the possible risks for some individuals. However, physicians are advised not to use regimens containing Viracept for pediatric or pregnant patients beginning HIV or antiretroviral treatments until further notice.
Source: United Press International
Related Links: CDC; Scorecard; Environmental Mutagen Society; natap.org; Medical News TODAY
Related Podcast: Having a Baby When You’re HIV Positive
from THE BODY
Tags: cancer; AIDS; protease inhibitor; HIV drugs; pharmaceuticals
Print This
|
|
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
Browse All Categories: Next article: Duke’s Drug Combo Could Treat a Resistant Melanoma
Previous article: Doctors Turn to Isabel for Answers
